Related Experiment Video
Updated: Dec 1, 2025

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.9K
Circular RNA circ-PRKCI promotes lung cancer progression by binding to microRNA-1324 to regulate MECP2 expression
1Department of Respiratory Medicine, Shandong Shanxian Central Hospital, Heze, China. 12124806@cumt.edu.cn.
European Review for Medical and Pharmacological Sciences
|November 6, 2020
Summary
Circular RNA PRKCI (circ-PRKCI) is highly expressed in lung cancer (LCa), promoting tumor progression and poor prognosis. Inhibition of circ-PRKCI suppresses LCa cell invasiveness and proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer (LCa) remains a leading cause of cancer mortality worldwide.
- Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer development.
- The specific function of circ-PRKCI in LCa pathogenesis is not well understood.
Purpose of the Study:
- To investigate the expression levels of circ-PRKCI in lung cancer.
- To elucidate the molecular mechanism by which circ-PRKCI influences LCa progression.
- To determine the prognostic value of circ-PRKCI in LCa patients.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) and Western blotting were used to assess circ-PRKCI and MECP2 expression.
- Cell Counting Kit-8 (CCK-8), clone formation, and transwell invasion assays evaluated cell proliferation and invasiveness.
- Dual-luciferase reporter assays verified the interaction between circ-PRKCI, microRNA-1324, and MECP2.
Main Results:
- Circ-PRKCI expression was significantly elevated in LCa tissues and cell lines compared to normal controls.
- High circ-PRKCI levels correlated with poorer prognosis in LCa patients.
- Inhibition of circ-PRKCI suppressed LCa cell proliferation and invasion in vitro.
- Circ-PRKCI was found to bind to microRNA-1324, competing with MECP2.
Conclusions:
- Circ-PRKCI is upregulated in lung cancer and associated with adverse patient outcomes.
- Circ-PRKCI promotes LCa progression by sponging microRNA-1324 and affecting the MECP2 pathway.
- Circ-PRKCI represents a potential diagnostic biomarker and therapeutic target for lung cancer.
Related Concept Videos
MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs
23.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.4K
MAPK Signaling Cascades
7.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
mTOR Signaling and Cancer Progression
4.3K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.3K
Master Transcription Regulators
7.5K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.5K
Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K

